top of page

BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
Consumer Products Relaunch Set for October Under a Company-Owned Model; Clyra Medical Scaling Ahead of a Second Product Launch; Company to Host Stockholder Town Hall on September 10, 2026 WESTMINSTER, CA / ACCESS Newswire / August 17, 2026 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today announced that it has filed its Quarterly Report on Form 10-Q for the three and s
3 days ago
BioLargo's Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons
The patented AEC removes more than 99% of PFAS chemicals in water, consistently exceeding state and federal requirements, and generates a fraction of the waste of conventional methods. WESTMINSTER, CA / ACCESS Newswire / August 3, 2026 / BioLargo, Inc. (OTCQX:BLGO), an environmental engineering company developing and commercializing sustainable technologies, today announced that its patented Aqueous Electrostatic Concentrator (AEC) has treated more than two million gallons of
Aug 10
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors
Company to contribute commercial PFAS treatment expertise alongside leading universities, regulators, utilities, and industry organizations advancing next-generation PFAS solutions. WESTMINSTER, CA / ACCESS Newswire / July 30, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services and solution provider, announced that it has joined the New Jersey PFAS Partnership Innovation Consortium (NJ PFAS-PIC), an NJIT-led initiative focused
Jul 30
BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar
Tonya Chandler will lead a seven-hour continuing education course for the fourth consecutive year at one of the water industry's largest regional gatherings WESTMINSTER, CA / ACCESS Newswire / July 29, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator that creates and commercializes sustainable technologies to solve tough environmental challenges, announced that Tonya Chandler, will lead a workshop titled "PFAS 101 - Everything You Didn't Want to Kno
Jul 30
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
Company leaders join environmental attorneys, academic researchers, and industry innovators in a special issue on forever chemicals and the protection of clean water WESTMINSTER, CA / ACCESS Newswire / July 27, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced the publication of the Q1/Q2 2026 edition of The Disruptive Quarterly (TDQ), titled "Water and Our Common Heritage: Facing the Challenge of Forever Chemicals." This latest TDQ
Jul 30
BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo. WESTMINSTER, CA / ACCESS Newswire / July 13, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it is preparing to relaunch CupriDyne®-based consumer pet products
Jul 13
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
BLEST Renews Air Quality Compliance Work at Five Air Force Bases Across New Mexico and Arizona WESTMINSTER, CA / ACCESS Newswire / July 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that its engineering subsidiary, BioLargo Engineering, Science & Technologies (BLEST), has received contract renewals totaling more than $1.4 million over 12 months to continue providing air quality and en
Jul 6
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
Agreement Extends Clyra's International Reach Through One of the Region's Premier Healthcare Distributors WESTMINSTER, CA / ACCESS Newswire / May 5, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that its subsidiary Clyra Medical Technologies, Inc. has entered into an exclusive distribution agreement with Al- Hikma FZCO, headquartered in Dubai, United Arab Emirates, to commercialize ViaCLYR™ across a broad territory spanning the G
May 5
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
WESTMINSTER, CA / ACCESS Newswire / May 4, 2026 / BioLargo Equipment Solutions & Technologies, Inc. ("BioLargo Equipment"), a subsidiary of BioLargo, Inc. (OTCQX:BLGO), an environmental engineering company developing and commercializing sustainable technologies, today announced it has signed into a memorandum of understanding (MOU) with Aquatech to advance the integration and commercialization of BioLargo's proprietary Aqueous Electrostatic Concentrator (AEC) for PFAS treatme
May 5
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
A meeting transcript will be published by 8-K prior to the market open the next day WESTMINSTER, CA / ACCESS Newswire / May 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that BioLargo's CEO Dennis P. Calvert will participate in a town hall meeting on May 5, 2026 at 1:00 PM Pacific Time, hosted on the BioLargo Shareholder Community Discord channel. The format: brief company update followed by Q&A with shareholders. The meeting
May 5
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
WESTMINSTER, CA / ACCESS Newswire / April 20, 2026 / BioLargo, Inc. (OTCQX:BLGO) , a cleantech innovator focused on sustainable water and environmental solutions, announced that its engineering subsidiary, BioLargo Engineering, Science & Technologies, Inc. (BLEST), has been awarded a $1.2 million contract to design a pilot-scale minerals processing facility that will support the remediation and beneficial reuse of a legacy mineral waste deposit associated with a historically
Apr 21
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
BioLargo sponsors legal and technical forum on PFAS contamination; company's PFAS remediation technology to be featured on a technical panel alongside leading environmental engineering firms, followed by a special screening of the film "Revealed: How to Poison a Planet." WESTMINSTER, CA / ACCESS Newswire / April 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that CEO Dennis P. Calvert and Tonya Chandler, President of BioLargo
Apr 2
BioLargo Reports Annual 2025 Operating and Financial Results
A Year of Disciplined Execution as BioLargo Gained Commercialization for Several Business Segments with $3.9 Million Cash Balance at Year End WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 5, 2026 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today announced that its Annual Report for the year ended December 31, 2025. To view the filing in its entirety, please see:..
Mar 9
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, March 5 th , 2026, at 9:00 am Pacific / 12:00 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending December 31 st , 2025, discuss recen
Mar 9
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
Clinical Experience Presented at Boswick Symposium Shows Rapid Wound Transformation, Enhanced Healing, and Strong Antimicrobial Performance Across Multiple Wound Types WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 18, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that clinical experience with ViaCLYR™, Clyra Medical Technologies' advanced wound irrigation solution powered by its proprietary Clyrasept™ technology, was pres
Feb 18
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
Initial Distribution Launch Marks Transition to Revenue-Generating Operations WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, announced today that its subsidiary, Clyra Medical Technologies, Inc., has received its first commercial stocking order from Advanced Solution, LLC for ViaCLYR™, Clyra's FDA-cleared wound irrigation solution. The order marks the start of commercial distribution and r
Feb 9
BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey
WESTMINSTER, CALIFORNIA / ACCESS Newswire / January 27, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed at the Lake Stockholm municipal water facility in New Jersey. BioLargo CEO Dennis Calvert commented, "The Lake Stockholm installation marks an important milestone for BioLargo as its AEC technology transitions into real-life municipal use. Once the facility goes through
Jan 27
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 29, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that it had delivered an open letter to its stockholders as follows: Dear Stockholders, As the world enters what may be one of the largest infrastructure and technology investment cycles in history, BioLargo, Inc. (OTCQX: BLGO), a developer of innovative technologies addressing environmental, en
Dec 29, 2025
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
Lake Stockholm, NJ AEC System Delivered and Preparing to Go Live WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that its subsidiary, BioLargo Equipment Solutions & Technologies, Inc. , has been prominently featured in Chemical Engineering magazine for its advances in electrostatic PFAS ("forever chemicals") treatment technology. The article,
Dec 3, 2025
BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025
Westminster, California--(Newsfile Corp. - November 21, 2025) - BioLargo, Inc. (OTCQX: BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and cleantech problems, today announced it will be presenting at Noble Capital Markets' 21 st Annual Emerging Growth Equity Conference at Florida Atlantic University, College of Business Executive Education in Boca Raton, FL on December 3 rd , 2025 at 10:30 AM Eastern Time. BioLarg
Nov 21, 2025
bottom of page
